SCHEMBL7588285

SCHEMBL7588285

CC(C)CCN(C(=O)c1ccc(-c2csc(N3CCN(C(=O)OC(C)(C)C)CC3)n2)cc1)C(=O)N(C)C#N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.45
LMNA P02545 4/20 0.45
MAPK1 P28482 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
TSHR P16473 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HTT P42858 1/20 0.45
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 1/20 0.40
ENPP2 Q13822 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CTSL P07711 4/20 0.39
CTSB P07858 4/20 0.39
CTSS P25774 4/20 0.39
USP30 Q70CQ3 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GPR119 Q8TDV5 3/20 0.38
ITGB2 P05107 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6183250 0.91 MAPT (0.44) MAPTLMNAMAPK1SMN1; SMN2TSHR
SCHEMBL7586301 0.91 MAPT (0.56) MAPTLMNAMAPK1SMN1; SMN2TSHR
SCHEMBL7544949 0.89 RAB9A (0.49) MAPTLMNAMAPK1SMN1; SMN2TSHR
SCHEMBL6183082 0.88 CTSS (0.46) MAPTLMNAMAPK1SMN1; SMN2TSHR
SCHEMBL7586450 0.87 GPR119 (0.41) GPR119NR1H2NR1H3
SCHEMBL6182283 0.86 CTSB (0.44) MAPTLMNAMAPK1SMN1; SMN2TSHR
SCHEMBL7429753 0.82 MAPK1 (0.45) MAPTLMNAMAPK1SMN1; SMN2TSHR
SCHEMBL6182191 0.79 MAPT (0.55) MAPTLMNAMAPK1SMN1; SMN2TSHR
SCHEMBL7542094 0.79 HRH3 (0.39) NPC1RAB9ACTSBCTSSUSP30
SCHEMBL6183359 0.77 ENPP2 (0.46) MAPTLMNAMAPK1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001068645-A2 N-CYANOMETHYLCARBOXAMIDES AND THEIR USE AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-09-20 WO claimed